info_outline
When AI Meets Biology: The Race Between Innovation and Oversight
02/10/2026
When AI Meets Biology: The Race Between Innovation and Oversight
Biotechnology is advancing faster than ever before, and the stakes have never been higher. In this episode, Dr. Christopher Cummings, lead for the Center for Health Engineering with the U.S. Army Corps of Engineers, breaks down why the convergence of biotech and artificial intelligence is creating both unprecedented opportunities and existential risks. From gene-edited foods that could revolutionize agriculture to AI-designed viruses that could destabilize nations, Dr. Cummings explores the delicate balance between innovation and oversight. He reveals why traditional regulatory frameworks are struggling to keep pace and how "information hazards" are forcing scientists to rethink transparency itself. We dive into the ethical minefield of black-boxed AI systems, designing biological solutions, the growing trust gap between lab and consumer, and what it means when AI can "de-skill" biotechnology to the point where expertise is no longer required to create dangerous organisms. Topics covered: CRISPR and gene editing, AI convergence, biosafety and bioweapons, public trust in GMOs, generational attitudes toward biotech, risk communication, international cooperation, and the future of governance in an accelerating technological landscape.
/episode/index/show/societyriskanalysis/id/40065175
